ID
29931
Descripción
Study ID: 102123 Clinical Study ID: FFR102123 Study Title: A randomised double-blind placebo controlled parallel group multicentre long term study to evaluate the safety of once-daily, intranasal administration of GW685698X aqueous nasal spray 100mcg* for 52 weeks in adult and adolescent subjects with perennial allergic rhinitis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: FLUTIDE, Allermist, Veramyst, FLUNASE, FLIXOTAIDE, FLUTAIDE, FLIXOVATE, Avamys; Veramyst, Avamys, Allermist Study Indication: Rhinitis, Allergic, Perennial This ODM-file contains Repeat 12-lead-ECG.
Palabras clave
Versiones (1)
- 27/4/18 27/4/18 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
27 de abril de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety of once-daily administration of Fluticasone nasal spray in adults and adolescents with perennial allergic rhinitis GSK 102123
Repeat 12-lead-ECG
- StudyEvent: ODM
Similar models
Repeat 12-lead-ECG
- StudyEvent: ODM
C0205341 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])